that’sit Programme (Tuberculosis, HIV, Aids, Treatment Support and Integrated Therapy) 

This project, in collaboration with the MRC, aims to expand the delivery of ART to TB patients in South Africa and promote TB screening in HIV-positive patients, using lessons learnt from the best practice models developed by other MRC partners. 

TB, although curable, is one of the most common causes of HIV-related morbidity and mortality in South Africa and in other African countries. Owing to a lack of awareness and education patients often present very late for help at healthcare facilities. What is more, the diagnosis of TB in association with HIV infection is not always straightforward. The project aims, therefore, to intensify TB screening in all HIV-positive patients.

South Africa has TB incidence rates ranging from 400 to 1500/100,000 compared to the USA, which has incidence rates of <16/100,000. In view of international interest following the Tugela Ferry outbreak of XDR TB in 2006 in KwaZulu-Natal this programme is well placed and focuses on TB patients as an entry point to access ART. At the same time the programme targets HIV-infected patients to heighten the awareness of TB signs and symptoms so that they can present in time to the relevant health authorities for TB diagnosis, treatment, and clinical interventions.

Read more about that'sit

Visit the that'sit website